RHAG and neoplasm: The results demonstrated that ACGs and Rh2 have good synergistic anti-tumor activity, and co-loaded liposomes enhanced anti-glioma activity and tumor targeting ability, and reduce the toxic effects of ACGs (Scheme 1).